Fig. 5.

Correlation between MM disease parameters, GvHD and Adoptive T cell Therapy strategies. Infiltration of MM cells in spleen (a) and bone marrow (b) and levels of M315 myeloma protein (μg/ml) in sera of mice (c) for MM-Auto-BMT control group and ATCT groups. Three mice per group were sacrifice 2 days before transplantation, 10 and 17 days after transplantation and at the end point. Data are expressed as the mean ± SD. MOPC cells identified as CD138⁺CD4⁺ double positive cells by flow cytometry staining